ribitol-5-phosphate has been researched along with Limb-Girdle Muscular Dystrophies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beedle, AM; Bourg, N; Charton, K; Foltz, SJ; Gicquel, E; Maizonnier, N; Martin, WJ; Richard, I; Svinartchouk, F | 1 |
1 other study(ies) available for ribitol-5-phosphate and Limb-Girdle Muscular Dystrophies
Article | Year |
---|---|
AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.
Topics: Animals; Disease Models, Animal; Dystroglycans; Gene Expression; Gene Expression Regulation; Genetic Therapy; Glycosylation; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophies, Limb-Girdle; Mutation; Pentosephosphates; Pentosyltransferases; Protein Binding; Protein Processing, Post-Translational; Proteins; Transferases | 2017 |